The contradictory results for the expression of H19, as well as the variability in the clinical characteristics of the patients, such as the timing in the progression of IR or T2D, the metabolic control, and the treatment, could contribute to the variation in the expression of lncRNAs. Here, H19 is linked to type 2 diabetes mellitus.